Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 21255816)

1.

Antibody-mediated neutralization of flaviviruses: a reductionist view.

Dowd KA, Pierson TC.

Virology. 2011 Mar 15;411(2):306-15. doi: 10.1016/j.virol.2010.12.020. Epub 2011 Jan 20. Review.

2.

Functions of Antibodies.

Forthal DN.

Microbiol Spectr. 2014 Aug;2(4). doi: 10.1128/microbiolspec.AID-0019-2014.

PMID:
26104200
3.

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host.

Kuhn RJ, Dowd KA, Beth Post C, Pierson TC.

Virology. 2015 May;479-480C:508-517. doi: 10.1016/j.virol.2015.03.025. Epub 2015 Mar 30. Review.

PMID:
25835729
4.

A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.

Pierson TC, Diamond MS.

Prog Mol Biol Transl Sci. 2015;129:141-66. doi: 10.1016/bs.pmbts.2014.10.005. Epub 2014 Dec 1.

PMID:
25595803
5.

Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.

Dowd KA, Mukherjee S, Kuhn RJ, Pierson TC.

J Virol. 2014 Oct;88(20):11726-37. doi: 10.1128/JVI.01140-14. Epub 2014 Jul 30.

6.

Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.

Galula JU, Shen WF, Chuang ST, Chang GJ, Chao DY.

J Virol. 2014 Sep;88(18):10813-30. doi: 10.1128/JVI.00810-14. Epub 2014 Jul 9.

7.

Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.

Yamanaka A, Suzuki R, Konishi E.

Vaccine. 2014 Jul 23;32(34):4289-95. doi: 10.1016/j.vaccine.2014.06.017. Epub 2014 Jun 17.

PMID:
24950360
8.

Mechanism and significance of cell type-dependent neutralization of flaviviruses.

Mukherjee S, Dowd KA, Manhart CJ, Ledgerwood JE, Durbin AP, Whitehead SS, Pierson TC.

J Virol. 2014 Jul;88(13):7210-20. doi: 10.1128/JVI.03690-13. Epub 2014 Apr 16.

9.

Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection.

Mukherjee S, Pierson TC, Dowd KA.

Methods Mol Biol. 2014;1138:75-97. doi: 10.1007/978-1-4939-0348-1_6.

PMID:
24696332
10.

Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.

Chaichana P, Okabayashi T, Puiprom O, Sasayama M, Sasaki T, Yamashita A, Ramasoota P, Kurosu T, Ikuta K.

PLoS One. 2014 Mar 18;9(3):e92173. doi: 10.1371/journal.pone.0092173. eCollection 2014.

11.

Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.

Lisova O, Belkadi L, Bedouelle H.

J Mol Recognit. 2014 Apr;27(4):205-14. doi: 10.1002/jmr.2352.

PMID:
24591178
12.

Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization.

Kolawole AO, Li M, Xia C, Fischer AE, Giacobbi NS, Rippinger CM, Proescher JB, Wu SK, Bessling SL, Gamez M, Yu C, Zhang R, Mehoke TS, Pipas JM, Wolfe JT, Lin JS, Feldman AB, Smith TJ, Wobus CE.

J Virol. 2014 Apr;88(8):4543-57. doi: 10.1128/JVI.03685-13. Epub 2014 Feb 5.

13.

Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.

Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE Jr, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS.

Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1939-44. doi: 10.1073/pnas.1317350111. Epub 2014 Jan 2. Erratum in: Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):6115.

14.
15.

The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.

VanBlargan LA, Mukherjee S, Dowd KA, Durbin AP, Whitehead SS, Pierson TC.

PLoS Pathog. 2013;9(12):e1003761. doi: 10.1371/journal.ppat.1003761. Epub 2013 Dec 5.

16.

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.

Freed DC, Tang Q, Tang A, Li F, He X, Huang Z, Meng W, Xia L, Finnefrock AC, Durr E, Espeseth AS, Casimiro DR, Zhang N, Shiver JW, Wang D, An Z, Fu TM.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E4997-5005. doi: 10.1073/pnas.1316517110. Epub 2013 Dec 2.

17.

Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease.

Beck C, Jimenez-Clavero MA, Leblond A, Durand B, Nowotny N, Leparc-Goffart I, Zientara S, Jourdain E, Lecollinet S.

Int J Environ Res Public Health. 2013 Nov 12;10(11):6049-83. doi: 10.3390/ijerph10116049. Review.

18.
19.

Therapeutic antibodies as a treatment option for dengue fever.

Chan KR, Ong EZ, Ooi EE.

Expert Rev Anti Infect Ther. 2013 Nov;11(11):1147-57. doi: 10.1586/14787210.2013.839941. Epub 2013 Oct 4. Review.

PMID:
24093625
20.

Natural exposure of horses to mosquito-borne flaviviruses in south-east Queensland, Australia.

Prow NA, Tan CS, Wang W, Hobson-Peters J, Kidd L, Barton A, Wright J, Hall RA, Bielefeldt-Ohmann H.

Int J Environ Res Public Health. 2013 Sep 17;10(9):4432-43. doi: 10.3390/ijerph10094432.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk